Status:

COMPLETED

Sleep Homeostasis in Primary Insomnia

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

American Academy of Sleep Medicine

Conditions:

Primary Insomnia

Eligibility:

All Genders

25-55 years

Phase:

NA

Brief Summary

About 10% of the population is believed to suffer from Primary Insomnia. It is also believed that people with chronic insomnia have a sleep system that is essentially out of alignment (we call this "h...

Detailed Description

Despite the magnitude of the problem of Primary Insomnia, and the good efficacy of Cognitive Behavioral Treatment for Insomnia (CBT-I), little is known about the pathophysiology of insomnia or whether...

Eligibility Criteria

Inclusion

  • Primary Insomnia (PI) subjects:
  • Difficulty falling or staying asleep for 6 or more months as evidenced by (a) 30 or more minutes to fall asleep on 3 or more nights per week, or (b) early morning awakenings \> 30 minutes prior to desired rise time on 3 or more nights per week
  • Reported impaired daytime function attributed to insomnia
  • Good-Sleeper (GS) controls:
  • No history of sleep disorders
  • No current sleep complaints and/or complaints of daytime fatigue or sleepiness
  • Sleep characterized as restorative and relatively "unperturbable"; and will be defined as: 5-15 minutes to fall asleep and no more than two awakenings per night of \> 5 minutes duration

Exclusion

  • Significant medical or psychiatric illness
  • Diagnosed or occult sleep disorders (evident on screening PSG) other than PI
  • Hearing or memory impairments
  • Non-fluency in spoken or written English
  • History of head injury (w/ loss of consciousness) or seizures
  • Prescription medication or recreational drug use within 4 weeks of laboratory study
  • Tobacco use or consume more than 3 cups of coffee per day (or an equivalent dose of caffeine)

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00256503

Start Date

December 1 2005

End Date

December 1 2008

Last Update

January 12 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester Medical Center

Rochester, New York, United States, 14642